Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.

Author: KeywoodCharlotte, SpieringsEgilius L H

Paper Details 
Original Abstract of the Article :
BACKGROUND: The chronic nature of migraine and the reliance on acute treatment constitute the basis of the present long-term, open-label study. OBJECTIVES: First, assessment of the tolerability and safety of frovatriptan, 2.5-7.5 mg taken orally over 24 hours, for the acute treatment of migraine, r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1526-4637.2009.00618.x

データ提供:米国国立医学図書館(NLM)

Frovatriptan: A Rapid Response for Migraine Relief

Migraines are a debilitating condition that affects millions worldwide, and finding effective and rapid relief is crucial for managing these episodes. This research investigates the effectiveness of frovatriptan, a medication used to treat acute migraine attacks. The study found that frovatriptan provided remarkably fast and high headache response in a significant subgroup of migraineurs, with low headache recurrence and minimal need for rescue medication. This indicates that frovatriptan could be a valuable tool for managing migraine attacks, especially for individuals who experience rapid relief.

A New Hope for Migraine Sufferers

These findings offer hope for those struggling with migraine headaches. Frovatriptan demonstrates the potential for rapid and effective relief, potentially reducing the debilitating impact of migraine attacks. This research emphasizes the importance of personalized approaches to migraine treatment, recognizing that different individuals may respond differently to medications.

Navigating Migraine Relief

Migraines can feel like a desert storm, with sudden onset and intense symptoms. Finding relief can be like searching for an oasis in the desert. This research suggests that frovatriptan might be the oasis for some migraine sufferers, providing rapid relief and reducing the frequency of attacks. It's a reminder that there is hope, and finding the right treatment strategy is crucial for managing this condition.

Dr. Camel's Conclusion

Frovatriptan is like a refreshing breeze in the desert, providing much-needed relief from the scorching heat of migraine attacks. This research highlights the potential for this medication to provide rapid and effective relief, offering hope for those struggling with migraines. It's a reminder that even in the midst of a debilitating condition, there are solutions available, and finding the right approach is key to navigating the challenges of migraine management.

Date :
  1. Date Completed 2009-11-13
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

19453958

DOI: Digital Object Identifier

10.1111/j.1526-4637.2009.00618.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.